# PAC_PAM
reanalysis of the data from a RCT study: Mabe, K., Okuda, M., Kikuchi, S., Amagai, K., Yoshimura, R., Kato, M., Sakamoto, N., Asaka, M., 2018. Randomized controlled trial: PPI-based triple therapy containing metronidazole versus clarithromycin as first-line treatment for Helicobacter pylori in adolescents and young adults in Japan. Journal of Infection and Chemotherapy 24, 538â€“543. https://doi.org/10.1016/j.jiac.2018.02.013
